Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

In a retrospective analysis of a single institution's experience with CA 19-9 as a marker in patients with pancreatic cancer, the absolute level prior to therapy, and the drop after treatment, was shown to be an independent prognostic factor for survival.

CA 19-9 and the Management of Pancreatic Cancer